V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008857 | 280006088 | 1.62 | 97 | Palliative (P) | 2013-08-27 | 2013-08-29 | Irinotecan + Modified De Gramont | 02 | N | 280029070 | VAI |
| 280008858 | 280006090 | null | 56.5 | Palliative (P) | 2017-11-26 | 2017-11-29 | Doxorubicin + Ifosfamide | null | null | 280029081 | DOXORUBICIN + IFOSFAMIDE |
| 280008859 | 280009189 | null | 69.85 | Neo-adjuvant (N) | null | 2017-04-20 | Cisplatin +Fluorouracil (3 wk) | null | null | 280029081 | CISPLATIN + FLUOROURACIL |
| 280008860 | 280006092 | 1.59 | 64.8 | Curative (C) | 2016-05-10 | 2016-05-16 | Oxaliplatin + Modified de Gramont | N | N | 280029090 | OXALIPLATIN + MDG |
| 280008861 | 280006094 | null | null | Adjuvant (A) | 2017-08-05 | 2017-09-06 | GEMCITABINE | N | N | 280029092 | GEMCITABINE |
| 280008862 | 280006094 | null | 81.2 | Palliative (P) | null | 2013-08-06 | CISPLATIN + FLUOROURACIL | null | null | 280029092 | CISPLATIN + FLUOROURACIL |
| 280008863 | 280006097 | 1.66 | 82.4 | Palliative (P) | 2018-06-09 | 2018-07-01 | Doxorubicin + Ifosfamide | N | N | 280029097 | DOXORUBICIN + IFOSFAMIDE |
| 280008864 | 280009193 | 1.78 | null | Adjuvant (A) | 2018-02-25 | 2018-02-25 | Irinotecan + Modified De Gramont | N | N | 280029099 | IRINOTECAN + TEMOZOLOMIDE |
| 280008865 | 280009193 | 1.66 | 72 | Curative (C) | 2014-10-29 | 2014-10-29 | Irinotecan + Modified De Gramont | N | N | 280029099 | VAI |
| 280008866 | 280011937 | null | 59.7 | Palliative (P) | 2016-11-12 | 2016-11-29 | EW EuroEwing 99 : VIDE | 2 | N | 280029101 | EURO-EWING |
| 280008867 | 280006099 | 1.77 | 80 | Palliative (P) | 2014-12-21 | 2014-12-22 | DE-ESCALATE TRIAL | 02 | N | 280029113 | DE-ESCALATE TRIAL |
| 280008868 | 280010681 | 1.75 | 80.3 | Curative (C) | 2015-07-15 | 2016-07-27 | Etoposide + Ifosfamide (5 days) | N | N | 280029116 | ETOPOSIDE + IFOSFAMIDE |
| 280008869 | 280010682 | 1.71 | 50.7 | Palliative (P) | 2015-03-13 | 2015-04-29 | Oxaliplatin + Modified de Gramont | 02 | null | 280029117 | OXALIPLATIN + MDG |
| 280008870 | 280006101 | 1.75 | 69.3 | Neo-adjuvant (N) | 2014-05-29 | 2014-06-19 | CISPLATIN + GEMCITABINE | N | null | 280029118 | CISPLATIN + GEMCITABINE |
| 280008871 | 280006101 | 1.81 | 95.6 | Adjuvant (A) | 2016-07-16 | 2016-11-29 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 280029118 | CARBOPLATIN + PACLITAXEL |
| 280008872 | 280006103 | 1.7 | 75.65 | Palliative (P) | 2015-07-26 | 2015-08-13 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 280029119 | CARBOPLATIN + PACLITAXEL |
| 280008873 | 280009200 | 1.77 | null | Palliative (P) | 2017-06-29 | 2017-07-18 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280029129 | CISPLATIN + GEMCITABINE |
| 280008874 | 280009200 | 1.85 | 62 | Palliative (P) | 2014-12-13 | 2014-12-13 | Gemcitabine weekly | 2 | N | 280029129 | GEMCITABINE |
| 280008875 | 280006106 | null | 88 | Palliative (P) | 2017-11-04 | 2017-12-13 | Gemcitabine weekly | N | N | 280029135 | GEMCITABINE |
| 280008876 | 280009201 | 1.49 | 66.8 | Adjuvant (A) | 2015-07-05 | 2015-07-05 | Doxorubicin + Ifosfamide | 02 | null | 280029135 | DOXORUBICIN + IFOSFAMIDE |
| 280008877 | 280006107 | 1.84 | 64.3 | Palliative (P) | 2014-04-20 | 2014-11-15 | Etoposide + Ifosfamide (5 days) | N | N | 280029140 | ETOPOSIDE + IFOSFAMIDE |
| 280008878 | 280006108 | null | 91.55 | Curative (C) | 2015-03-25 | 2015-04-15 | CISPLATIN + FLUOROURACIL | N | N | 280029142 | CISPLATIN + FLUOROURACIL |
| 280008879 | 280009203 | 1.66 | 55.8 | Adjuvant (A) | 2018-07-04 | 2018-07-04 | EW Rel rEECur Irinotecan/Temozolomide | 2 | N | 280029145 | VAI |
| 280008880 | 280009203 | 1.81 | null | Palliative (P) | 2016-02-29 | 2016-03-02 | EW EuroEwing 99 : VActC | 02 | N | 280029145 | EURO-EWING |
| 280008881 | 280006110 | 1.68 | 97.6 | null | 2014-11-08 | 2014-11-26 | Doxorubicin + Ifosfamide | N | N | 280029149 | DOXORUBICIN + IFOSFAMIDE |
| 280008882 | 280006112 | 1.65 | null | Palliative (P) | 2013-12-03 | 2013-12-06 | Capecitabine + Oxaliplatin 21day | 02 | N | 280029152 | CAPECITABINE + IRINOTECAN |
| 280008883 | 280006114 | 1.77 | 59.1 | Curative (C) | 2013-05-07 | 2013-05-07 | Docetaxel 75mg/m2 (21 day) | 02 | N | 280029156 | STREPTOZOCIN |
| 280008884 | 280006116 | 1.7 | 51.4 | Palliative (P) | 2014-08-08 | 2014-11-03 | Pazopanib | N | N | 280029161 | CAPECITABINE + OXALIPLATIN |
| 280008885 | 280006117 | 1.71 | 56.6 | null | 2014-08-01 | 2014-08-01 | Vincristine (weekly) | N | N | 280029162 | DOCETAXEL |
| 280008886 | 280009206 | 1.62 | 54 | Adjuvant (A) | 2015-10-29 | 2015-12-29 | EOX | N | N | 280029169 | CAPECITABINE |
| 280008887 | 280006119 | 1.69 | 54 | Palliative (P) | 2018-08-26 | 2018-09-09 | Pazopanib | N | null | 280029171 | FLUOROURACIL |
| 280008888 | 280006120 | 1.63 | 76.85 | Disease modification (D) | null | 2014-02-26 | Capecitabine | null | Y | 280029172 | SUNITINIB |
| 280008889 | 280009207 | 1.64 | 64.8 | Curative (C) | 2017-04-02 | 2017-04-10 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280029172 | PEMBROLIZUMAB |
| 280008890 | 280006121 | null | 51.5 | Curative (C) | 2014-02-08 | 2014-02-16 | Carboplatin + Liposomal Doxorubicin | 02 | N | 280029179 | SUNITINIB |
| 280008891 | 280006123 | 1.63 | null | Neo-adjuvant (N) | 2014-07-30 | 2014-08-30 | IVADo | 2 | N | 280029180 | ERLOTINIB |
| 280008892 | 280010691 | 0 | 52.2 | Palliative (P) | 2014-02-24 | 2014-03-02 | IVADo | N | null | 280029186 | EPIRUBICIN |
| 280008893 | 280011409 | 0 | 81.3 | Palliative (P) | 2015-08-18 | 2015-08-26 | Carboplatin + Cetux + FU (>Cycle 2) | N | Y | 280029187 | CETUXIMAB + IRINOTECAN + MDG |
| 280008894 | 280006124 | 1.8 | 59.1 | Adjuvant (A) | 2013-03-07 | 2013-04-25 | Cyclophosphamide + Vincristine | N | Y | 280029192 | CAPECITABINE + CARBOPLATIN |
| 280008895 | 280006126 | 1.8 | 86 | Palliative (P) | 2017-07-28 | 2017-10-13 | STS Rhabdo rel BERNIE Vinor Cyclo | null | null | 280029198 | CISPLATIN + PACLITAXEL |
| 280008896 | 280006127 | null | 100.6 | Palliative (P) | null | 2014-11-09 | Vinorelbine IV | N | N | 280029201 | SUNITINIB |
| 280008897 | 280006127 | 1.8 | 59 | Curative (C) | 2015-08-02 | 2015-08-27 | CYCLOPHOSPHAMIDE + ETOPOSIDE | 02 | N | 280029201 | BLEOMYCIN |
| 280008898 | 280006130 | 1.61 | 41.5 | Not known (9) | 2013-06-19 | 2013-07-29 | BEP 3 day | 99 | null | 280029221 | PEMBROLIZUMAB |
| 280008899 | 280006131 | 1.63 | 40.5 | Curative (C) | 2013-07-04 | 2013-07-25 | Capecitabine (14 days)+Carboplatin | N | null | 280029221 | FLUOROURACIL |
| 280008900 | 280006132 | 1.82 | 59.1 | Palliative (P) | 2015-11-06 | 2016-01-10 | Cisplatin + Fluorouracil + RT 5day | N | N | 280029223 | CAPECITABINE |
| 280008901 | 280006132 | 1.89 | 70.4 | Palliative (P) | 2015-09-20 | 2015-09-20 | Carboplatin + Docetaxel | 02 | N | 280029223 | GEMCARBO |
| 280008902 | 280006133 | 1.58 | 54.2 | Palliative (P) | 2016-06-02 | 2016-06-18 | CARBOPLATIN + GEMCITABINE | N | N | 280029255 | CISPLATIN + DACARBAZINE |
| 280008903 | 280006135 | 1.8 | null | Palliative (P) | 2016-05-25 | 2016-05-30 | Cisplatin + Fluorouracil + RT 5day | 2 | N | 280029257 | EOX |
| 280008904 | 280009214 | null | 85.2 | Neo-adjuvant (N) | 2013-11-26 | 2013-11-26 | AXI-STS TRIAL | null | null | 280029268 | EOX |
| 280008905 | 280009214 | 0 | 68 | Palliative (P) | 2016-11-27 | 2016-11-27 | Docetaxel | 02 | N | 280029268 | CARBOPLATIN + LIPOSOMAL DOX |
| 280008906 | 280011411 | null | null | Palliative (P) | 2013-12-07 | 2013-12-09 | Bevacizumab + Cape + Oxali 21day | 2 | null | 280029270 | VINORELBINE |